US 12065448
Heteroaryl plasma kallikrein inhibitors
granted A61PA61P29/02
Quick answer
US patent 12065448 (Heteroaryl plasma kallikrein inhibitors) held by Takeda Pharmaceutical Company Limited expires Mon Aug 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Aug 20 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61P, A61P29/02